epidermal-growth-factor and Cutis-Laxa

epidermal-growth-factor has been researched along with Cutis-Laxa* in 1 studies

Reviews

1 review(s) available for epidermal-growth-factor and Cutis-Laxa

ArticleYear
First report of a short in-frame biallelic deletion removing part of the EGF-like domain calcium-binding motif in LTBP4 and causing autosomal recessive cutis laxa type 1C.
    American journal of medical genetics. Part A, 2022, Volume: 188, Issue:11

    Cutis laxa (CL) is a rare connective tissue disorder characterized by wrinkled, abundant and sagging skin, sometimes associated with systemic impairment. Biallelic alterations in latent transforming growth factor beta-binding protein 4 gene (LTBP4) cause autosomal recessive type 1C cutis laxa (ARCL1C, MIM #613177). The present report describes the case of a 17-months-old girl with cutis laxa together with a literature review of previous ARCL1C cases. Based on proband main clinical signs (cutis laxa and pulmonary emphysema), clinical exome sequencing (CES) was performed and showed a new nine base-pairs homozygous in-frame deletion in LTBP4 gene. RT-PCR and cDNA Sanger sequencing were performed in order to clarify its impact on RNA. This report demonstrates that a genetic alteration in the EGF-like 14 domain calcium-binding motif of LTBP4 gene is likely responsible for cutis laxa in our patient.

    Topics: Calcium; Cartilage Diseases; Cutis Laxa; DNA, Complementary; Epidermal Growth Factor; Female; Gastrointestinal Diseases; Humans; Infant; Latent TGF-beta Binding Proteins; Respiratory Tract Diseases; RNA; Transforming Growth Factor beta; Urologic Diseases

2022